HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Clinical efficacy of corinfar retard in the treatment of patients with biliary tract dyskinesia].

Abstract
Corinfar-Retard efficacy in patients with hypertonic-hyperkinetic type of biliary dyskinesia has been studied. 56 patients aged 26 to 30 had been prescribed Corinfar-Retard in 20 mg per day for 7 days. Dynamic echocholecystography has applied. Decrease in contraction of gall bladder and normalization of tonic contraction of sphincter Ody was found in the patients with previously diagnosed hypertonic-hyperkinetic type of biliary dyskinesia after having been treated with Corinfar-Retard.
AuthorsV H Lyzohub, L S Nikoliuk, T V Zaval's'ka, D A Pliskevych
JournalLikars'ka sprava (Lik Sprava) Issue 2 Pg. 74-6 (Mar 2004) ISSN: 1019-5297 [Print] Ukraine
Vernacular TitleKlinichna efektyvnist' korynfaru retardu u likuvanni khvorykh z dyskineziieiu zhovchnovyvidnykh shliakhiv.
PMID15208881 (Publication Type: Journal Article)
Chemical References
  • Calcium Channel Blockers
  • Delayed-Action Preparations
  • Nifedipine
Topics
  • Adult
  • Biliary Dyskinesia (diagnostic imaging, drug therapy, physiopathology)
  • Calcium Channel Blockers (administration & dosage, therapeutic use)
  • Cholecystography
  • Delayed-Action Preparations
  • Humans
  • Middle Aged
  • Muscle Tonus (drug effects)
  • Muscle, Smooth (drug effects)
  • Nifedipine (administration & dosage, therapeutic use)
  • Sphincter of Oddi (drug effects)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: